On this program Ellis speaks with a new sponsor Brad Thompson, CEO of Oncolytics Biotech Inc. trading as ONCY on the NASDAQ and ONC on the TSX. Oncolytics has developed a REOVIRUS called REOLYSIN that attacks cancer tumors while leaving healthy cells alone. He’ll then chat with Harry Fleming, the President of Texas based Nobilis Health Trading on the TSX as NHC. Nobilis has successfully developed a cadre of boutique surgical centers in Houston, Dallas and Phoenix. We’ve seen their share price nearly triple since they began as a sponsor with us in January. David Morgan, of The Morgan re
|